132 related articles for article (PubMed ID: 3010623)
1. Characterization of immunoreactive corticotropin and corticotropin-releasing factor in human adrenal and ovarian tumours.
Suda T; Tomori N; Yajima F; Odagiri E; Demura H; Shizume K
Acta Endocrinol (Copenh); 1986 Apr; 111(4):546-52. PubMed ID: 3010623
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactive corticotropin and corticotropin-releasing factor in human hypothalamus, adrenal, lung cancer, and pheochromocytoma.
Suda T; Tomori N; Tozawa F; Demura H; Shizume K; Mouri T; Miura Y; Sasano N
J Clin Endocrinol Metab; 1984 May; 58(5):919-24. PubMed ID: 6323518
[TBL] [Abstract][Full Text] [Related]
3. Distribution and characterization of immunoreactive corticotropin-releasing factor in human tissues.
Suda T; Tomori N; Tozawa F; Mouri T; Demura H; Shizume K
J Clin Endocrinol Metab; 1984 Nov; 59(5):861-6. PubMed ID: 6332825
[TBL] [Abstract][Full Text] [Related]
4. A phaeochromocytoma presenting with Cushing's syndrome associated with increased concentrations of circulating corticotrophin-releasing factor.
Jessop DS; Cunnah D; Millar JG; Neville E; Coates P; Doniach I; Besser GM; Rees LH
J Endocrinol; 1987 Apr; 113(1):133-8. PubMed ID: 3035046
[TBL] [Abstract][Full Text] [Related]
5. Peptides related to the N-terminus of pro-opiomelanocortin in the human adrenal medulla.
Gaspar L; Chan JS; Seidah NG; Chrétien M
Clin Invest Med; 1989 Apr; 12(2):90-8. PubMed ID: 2539931
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactive corticotropin-releasing hormone, growth hormone-releasing hormone, somatostatin, and peptide histidine methionine are present in adrenal pheochromocytomas, but not in extra-adrenal pheochromocytoma.
Sasaki A; Yumita S; Kimura S; Miura Y; Yoshinaga K
J Clin Endocrinol Metab; 1990 Apr; 70(4):996-9. PubMed ID: 1969422
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin-releasing factor in the adrenal medulla.
Bruhn TO; Engeland WC; Anthony EL; Gann DS; Jackson IM
Ann N Y Acad Sci; 1987; 512():115-28. PubMed ID: 3502062
[TBL] [Abstract][Full Text] [Related]
8. Pituitary and hypothalamic hormones in normal and neoplastic adrenal medullae: biologically active corticotropin-releasing hormone and corticotropin.
Nicholson WE; DeCherney GS; Jackson RV; Orth DN
Regul Pept; 1987 Aug; 18(3-4):173-88. PubMed ID: 2823321
[TBL] [Abstract][Full Text] [Related]
9. Biological and immunological characterization of corticotropin-releasing activity in the bovine adrenal medulla.
Minamino N; Uehara A; Arimura A
Peptides; 1988; 9(1):37-45. PubMed ID: 2834703
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing factor (CRF)-like immunoreactivity in the adrenal medulla.
Hashimoto K; Murakami K; Hattori T; Niimi M; Fujino K; Ota Z
Peptides; 1984; 5(4):707-11. PubMed ID: 6333676
[TBL] [Abstract][Full Text] [Related]
11. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S
Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172
[TBL] [Abstract][Full Text] [Related]
12. Multiple endocrine neoplasia with Cushing's syndrome due to paraganglioma producing corticotropin-releasing factor and adrenocorticotropin.
Hashimoto K; Suemaru S; Hattori T; Sugawara M; Ota Z; Takata S; Hamaya K; Doi K; Chrétien M
Acta Endocrinol (Copenh); 1986 Oct; 113(2):189-95. PubMed ID: 2877533
[TBL] [Abstract][Full Text] [Related]
13. Presence of corticotropin-releasing factor-like immunoreactivity in human tumors.
Wakabayashi I; Ihara T; Hattori M; Tonegawa Y; Shibasaki T; Hashimoto K
Cancer; 1985 Mar; 55(5):995-1000. PubMed ID: 3871347
[TBL] [Abstract][Full Text] [Related]
14. Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease.
Suda T; Tozawa F; Mouri T; Sasaki A; Shibasaki T; Demura H; Shizume K
J Clin Endocrinol Metab; 1983 Jun; 56(6):1094-9. PubMed ID: 6302123
[TBL] [Abstract][Full Text] [Related]
15. CRF immunoreactive peptides in the human hypophysis: a cautionary note.
Bény JL; Corder R; Nieuwenhuijzen Kruseman AC; Lowry PJ
Peptides; 1985; 6(4):661-7. PubMed ID: 2999732
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing factor in humans. II. CRF stimulation in patients with diseases of the hypothalamo-pituitary-adrenal axis.
Müller OA; Stalla GK; von Werder K
Horm Res; 1987; 25(4):185-98. PubMed ID: 3034758
[TBL] [Abstract][Full Text] [Related]
17. Measurement of circulating corticotrophin-releasing factor in man.
Cunnah D; Jessop DS; Besser GM; Rees LH
J Endocrinol; 1987 Apr; 113(1):123-31. PubMed ID: 3035045
[TBL] [Abstract][Full Text] [Related]
18. Involvement of corticotropin-releasing factor and adrenocorticotropic hormone in the ovarian maturation, seawater acclimation, and induced spawning of Liza ramada.
Mousa SA; Mousa MA
Gen Comp Endocrinol; 2006 Apr; 146(2):167-79. PubMed ID: 16376890
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
Nakahara M; Shibasaki T; Shizume K; Kiyosawa Y; Odagiri E; Suda T; Yamaguchi H; Tsushima T; Demura H; Maeda T
J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
[TBL] [Abstract][Full Text] [Related]
20. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
